Nav: Home

Copper essential for burning fat, researchers find

June 10, 2016

Is copper deficiency contributing to the obesity epidemic?

Though small amounts of copper are essential to health - oysters, liver, beans and nuts are good sources - copper's role in metabolism has been unclear: Some studies found that it boosted fat burning, others that it depressed it.

University of California, Berkeley, Lawrence Berkeley National Laboratory and Howard Hughes Medical Institute researchers have now clarified the critical role that copper plays in nutrition: It helps move fat out of fat cells - called adipocytes - and into the blood stream for use as energy.

Without enough copper, fat builds up in fat cells without being utilized, said Christopher Chang, the Class of 1942 Chair and a professor of chemistry and of molecular and cell biology at UC Berkeley.

"Unlike other studies that link copper levels both to increased or decreased fat metabolism, our study shows definitively how it works - it's a signal that turns on fat cells," said Chang, who also is a faculty scientist at Berkeley Lab and a Howard Hughes Medical Institute investigator. "If we could find a way to burn fat more efficiently, this could be a big contribution to dealing with obesity and diabetes."

The new study appeared online this week, and will be published in the July print issue of the journal Nature Chemical Biology.

The findings point not only to a new role for copper in metabolism, but highlight the key role copper plays throughout the body. Previously, Chang showed that copper is a key signaling molecule in the brain, tamping down over-excitation of nerve cells.

"The work we have done with copper really shows that signaling is not restricted to just a few elements on the periodic table, like sodium, calcium and potassium," he said. "Copper is a brand new class; in a sense we have basically added a fourth letter to the alphabet, in terms of metal elements that contribute to the language of signaling."

The similar roles copper plays in regulating nerve cells and fat burning highlight a growing perception that the neurological system, specifically the brain, plays a role in diseases of metabolism and the immune system, such as obesity and inflammation.

"Some of us are now thinking about obesity as a neurological disease rather than strictly a metabolic disease, because there are potentially connections between your fat tissue and the brain," he said. "The notion that obesity and obesity-related diseases like diabetes may be neurological in nature opens the door to new basic science and therapeutic approaches."

Chang cautions against ingesting copper supplements as a result of these studies, however. Too much copper can lead to imbalances in other essential minerals, including zinc.

Copper-related diseases

With a longstanding interest in the biological roles of metals, Chang focused on fat metabolism after reading that copper is often given to cows to regulate weight gain. To discover how copper actually works in fat metabolism, he chose to study mice with a genetic defect that produces symptoms similar to those of a rare human illness, Wilson's disease. In both situations, a key enzyme that moves copper in and out of cells is mutated, causing misregulation and copper overload - often to toxic levels - in the liver. The condition is also characterized by bloated fat cells.

He and his team, in particular postdocs Lakshmi Krishnamoorthy and Joseph Cotruvo Jr., discovered that in the mice, copper is hoarded by the liver, basically starving fat cells of copper so that they cannot properly regulate fat storage and burning in organs such as the stomach and pancreas. This overload is accompanied by lower than normal levels of fats, or lipids, in the blood.

"Lipolysis is the breakdown of large pieces of fat into smaller pieces so they can circulate in the blood and be burned throughout the body," he said. "We discovered that in these Wilson's mice, low copper in the fat cells made them unable to burn fat as well as normal mice."

They succeeded in tracking down exactly how copper works: It releases a brake on fat burning. Normally, a second messenger molecule called cyclic-AMP (cAMP) activates the enzymes that break down the fat molecules. They found, however, that another enzyme (phosphodiesterase 3, or PDE3) blocks cAMP, probably to prevent fat breakdown when it is not needed, such as when we're couch potatoes. Copper blocks this enzyme, thereby "putting a brake on a brake," Chang said.

Chang is continuing his study of copper's roles in the brain and in fat metabolism, looking for possible ways to target the copper pathway to treat neurodegenerative brain diseases or diseases of metabolism. He also is looking at copper's roles in perception and sleep.

These studies have led him also to explore the connections between the central nervous system - the brain and spinal cord - and the peripheral nervous system, which innervates all our organs, and how that may cause disease.
-end-
The work was funded by the National Institutes of Health (GM 79465, GM067166, GM101502).

University of California - Berkeley

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...